Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications

Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications

US Patent 11945858 · Granted Apr 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered TGF-beta monomers and their use for inhibiting TGF-beta signaling2025
Anti-G-CSF antibodies and uses thereof2025
TGF-β-receptor ectodomain fusion molecules and uses thereof2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Blood-brain barrier transmigrating therapeutic compounds and uses thereof2025
Intrabodies for reducing FUT8 activity2025
Antibodies selective for cells presenting EGFR at high density2024
TGF-β-receptor ectodomain fusion molecules and uses thereof2024
Human blood brain barrier model2023
AXL-specific antibodies and uses thereof2023
Fusion protein comprising a blood-brain barrier (BBB)-crossing single domain ant2023
Fusion protein comprising a blood-brain barrier (BBB)-crossing single domain ant2023